registry – Page 31 – Communicable Diseases Research

Prognostic Value of Venous Thromboembolism Risk Assessment Models in Patients with Severe COVID-19

Original Article

Published on 2021-04-222022-10-29
Journal: TH Open: Companion Journal to Thrombosis and Haemostasis [Category] COVID-19,

The proportion and effect of corticosteroid therapy in patients with COVID-19 infection: A systematic review and meta-analysis

COVID-19 감염 환자에서 코르티코스테로이드 요법의 비율과 효과: 체계적인 검토 및 메타 분석

Meta-Analysis

Published on 2021-04-212022-09-10
Journal: PLoS ONE [Category] MERS, SARS, 임상,

[키워드] 95% confidence interval acute respiratory syndrome acute respiratory syndrome coronavirus addition Analysis Anti-inflammatory articles China clinical trial clinical trials Comprehensive conducted Controlled coronavirus coronavirus disease Coronavirus disease 2019 Corticosteroid corticosteroid therapy corticosteroid treatment Corticosteroids COVID-19 COVID-19 patient COVID-19 patients demonstrated died effect size Efficacy evaluate extreme ICU immunosuppressive drug immunosuppressive drugs IMPROVE indicate Infection intensive care intensive care unit journal literature review mean difference Meta-analysis Mortality network no significant difference not correlated objective observational studies observational study Odds ratio outcome outcome measure outcome measures outcomes Patient patients treated patients with COVID-19 performed proportion proportions receive registry reported Research respiratory Result severe acute respiratory syndrome Coronavirus significantly significantly higher significantly lower stratified Subgroup analyses subject systematic review The effect size those who survived treated Treatment treatment of COVID-19 Trial use of corticosteroid Viral viral clearance
[DOI] 10.1371/journal.pone.0249481 PMC 바로가기 [Article Type] Meta-Analysis

Impact of COVID-19 Pandemic on Total Mortality in Poland

Communication

Published on 2021-04-202022-10-30
Journal: International Journal of Environmental Research an [Category] COVID-19, MERS, SARS,

[키워드] coronavirus country COVID-19 COVID-19 mortality death deaths epidemiological data estimation Impact increase in Ministry of Health Mortality office Poland registry secondary Silesia Total total mortality were used
[DOI] 10.3390/ijerph18084388 PMC 바로가기 [Article Type] Communication

The World Heart Federation Global Study on COVID-19 and Cardiovascular Disease

Original Research

Published on 2021-04-192022-10-31
Journal: Global Heart [Category] COVID-19, MERS,

[키워드] acute renal failure Admission adult COVID-19 patient asymptomatic phase cardiovascular cardiovascular disease Cardiovascular events cardiovascular risk factor caused Chagas disease Cohort Community coronavirus country COVID-19 COVID-19 patient CVD death discharge effective facilitated Federation healthcare heart HIV hospital Hospitalized ICU admission include International manifestation neurological novel coronavirus disease Observational cohort study outcome outcomes pandemic Patient patients hospitalized prognostic recruited Region registry reported required respiratory rheumatic heart disease risk factor SARS-CoV-2 severe disease survey Transmission transmitted Travel ventilator with COVID-19
[DOI] 10.5334/gh.950 PMC 바로가기 [Article Type] Original Research

Neurological presentations of COVID-19: Findings from the Spanish Society of Neurology neuroCOVID-19 registry

Observational Study

Published on 2021-04-152022-10-05
Journal: Journal of the neurological sciences [Category] SARS, 임상,

[키워드] age Altered Altered mental status Analysis Anosmia categories cerebrospinal fluid Combination Course COVID-19 delirium differential diagnoses epilepsy finding General symptom greater headache Headache disorders Laboratory Manifestations Mental multicentre myalgia neurological manifestation Neurological symptom Neurological symptoms NEUROLOGY occur occurred Onset onset of symptom Patient patients performed physician positive result proportion radiological registry reported SARS-CoV-2 Seizure severity Society Spanish Standard deviation stroke submitted Symptom Symptoms symptoms appeared the disease was performed was recorded women
[DOI] 10.1016/j.jns.2020.117283 PMC 바로가기 [Article Type] Observational Study

Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

무작위 시험의 국제 협력 메타 분석에서 COVID-19에서 히드록시클로로퀸과 클로로퀸의 사망률 결과

Meta-Analysis

Published on 2021-04-152022-09-10
Journal: Nature Communications [Category] MERS, SARS, 바이오마커, 임상, 치료법,

[키워드] 95% CI 95% confidence interval all-cause mortality Analysis benefit bioRxiv children Chloroquine CIs clinical clinical trials Comorbidities COVID-19 COVID-19 patient COVID-19 patients COVID-19 research diagnostic Effect Effects eligible Epidemiology Evidence finding Generalizability High dose Hydroxychloroquine hydroxychloroquine/chloroquine include increased mortality International investigated investigator investigators medRxiv Meta-analysis Mortality Odds ratio Odds ratios outcome outpatients Patient patients Potential treatment Pragmatic pregnant women random-effects meta-analyses randomized clinical trial randomized trial RCT RCTs recovery recruitment registry Result survival total sample size Treatment Trial trials viral infection WHO WHO International Clinical Trials Registry Platform
[DOI] 10.1038/s41467-021-22446-z PMC 바로가기 [Article Type] Meta-Analysis

Multicentre randomised double-blinded placebo-controlled trial of favipiravir in adults with mild COVID-19

경증 COVID-19 성인을 대상으로 한 favipiravir의 다기관 무작위 이중 맹검 위약 대조 시험

Article

Published on 2021-04-142022-09-11
Journal: BMJ Open [Category] 임상,

[키워드] 1:1 Affair approved blinded by mouth caused clinical clinical trials control group Coronavirus infection COVID-19 COVID-19 sample Cox proportional hazard regression decrease diagnosed disease onset double-blind double-blinded dropout rate Efficacy and safety Eligible participants Ethics evaluate the effect evaluated Evidence Favipiravir follow-up period followed by hazard ratio healthcare hypothesise Infectious diseases institutional review board intention to treat International King lack limit medication men Mild Ministry of Health mouth nonpregnant Novel coronavirus outbreak outcome participant Patient PCR PCR test peer-reviewed per day physician Placebo placebo-controlled trial positive potential therapy primary analysis population Primary outcome randomised Randomised trial recruit recruited registration number registry reported required Respiratory illness SARS-CoV-2 subject swab sample symptomatic patient Symptomatic patients the timing therapeutic agent Therapeutics therapy treat treated Treatment Virology virus virus clearance women
[DOI] 10.1136/bmjopen-2020-047495 PMC 바로가기 [Article Type] Article

Underlying heart diseases and acute COVID-19 outcomes

Article

Published on 2021-04-132023-06-16
Journal: Cardiology journal [Category] MERS, SARS,

[키워드] Cardiology COVID-19 heart disease Mortality Prognosis registry
[DOI] 10.5603/CJ.a2020.0183 PMC 바로가기

The Impact of COVID-19 Pandemic on Children with Pulmonary Arterial Hypertension. Parental Anxiety and Attitudes. Follow-Up Data from the Polish Registry of Pulmonary Hypertension (BNP-PL)

Article

Published on 2021-04-122022-10-30
Journal: Journal of Clinical Medicine [Category] COVID-19,

Therapeutic respiratory and functional rehabilitation protocol for intensive care unit patients affected by COVID-19: a structured summary of a study protocol for a randomised controlled trial

COVID-19의 영향을 받는 중환자실 환자를 위한 치료 호흡 및 기능 재활 프로토콜: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약

Letter

Published on 2021-04-122022-09-10
Journal: Trials [Category] MERS, 임상,

[키워드] 1:1 6-minute walk test activities activity Admission Adult patients affected age Agitation approved assessment balanced randomization blinded Blinding block blocks Borg both groups Care clinical status clinical trial Coma Comorbidities Comorbidity comparator conducted confidentiality cooperation COVID-19 criteria Critical Critical illness daily living Data collection defined discharge dissemination distribution of patient double-blind Douro Dyspnea Effect element eligible Endpoint evaluate evaluated evaluator exertion expected Follow-up for inclusion form functional functional capacity functional rehabilitation Glasgow coma scale group Handgrip strength test Health Health Service Health services Hospital stay Hospitalization Hospitalized hospitalized COVID-19 patients ICU incidence include independent intensive care intensive care unit Intervention intervention group life mechanical ventilation Medical Research Council Medicine Mobility Monday need for oxygen number Nurse nursing care objective occupational therapy occur outcome outcome measure outcomes oxygen Oxygen therapy participant Participants Patient per day Perceived physical Physical assessment physical rehabilitation Physiotherapist Physiotherapy Portugal positioning post-intensive care syndrome Potential Potential participants primary outcome measure progression protocol Quality of life question randomisation randomised randomised controlled trial randomization sequence Randomized Randomized controlled trial readmission reassurance receive recommendation recorded recruited referred to Registered registry rehabilitation rehabilitation exercises rehabilitation medicine respiratory respiratory insufficiency respiratory rehabilitation Respiratory system responsible Sample size Saturday scale Secondary objectives sequence Sex Society stability standard care Standard of care status strength test study group Study protocol subject suctioning supplementary material survey survival Test the patient therapy Tolerance treated Treatment Trial registration two groups verbal website
[DOI] 10.1186/s13063-021-05210-y PMC 바로가기 [Article Type] Letter